Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1424PDF: 1122HTML: 450 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
947PDF: 561HTML: 254Suppl. Files: 356 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2370PDF: 903HTML: 977Patient’s family tree: 234 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1499PDF: 885HTML: 8680Fig 3 Savini: 226Fig 2 Savini: 238Fig 1 Savini Chest TC: 234Author letter to referees: 238 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4990PDF: 1888HTML: 2882Untitled: 301 -
Allogeneic transplantation in patients with advanced systemic mastocytosis: case report of a single center experience Allogeneic Transplantation in Systemic Mastocytosis
2146PDF: 168HTML: 46 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1308PDF: 657HTML: 2918ATRA induced Reactive Hemophagocytosis: A Case Report: 244 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4213PDF: 1235HTML: 2120Fig.1: 248Fig. 2: 140Table 1: 252Table2: 274Table 3: 248 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1798PDF: 2034Suppl. Files: 280HTML: 116 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4217PDF: 1329HTML: 2127Table 1: 238 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2269PDF: 916HTML: 377 -
EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
2359PDF: 1067HTML: 4991 -
Anemia in the elderly: not always what it seems.
3431PDF: 1151HTML: 1811Figure 1: 241Figure 1 revised: 258 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3431PDF: 1624HTML: 550 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3540PDF: 1335HTML: 8404 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2422PDF: 1020HTML: 515Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 269UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 408Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 300Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 225Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 240Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 316 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4943PDF: 1633HTML: 2276Untitled: 278Untitled: 298Untitled: 315Untitled: 266Untitled: 279 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1305PDF: 587HTML: 1718Figures: 213Fifures Sanz: 224tables Sanz: 227Untitled: 224 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1275PDF: 883HTML: 3421 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2452PDF: 798HTML: 2155Untitled: 276Untitled: 199Untitled: 231Untitled: 212Untitled: 221Untitled: 245Untitled: 234 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1397PDF: 1179PDF: 934HTML: 265







